Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Norman

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
MLO: Medical Laboratory Observer|August 26, 2015
Fecal calprotectin: an inflammatory biomarker with emerging importance in the clinical laboratoryGary L Norman
Journal of Clinical Gastroenterology|September 25, 2003
Autoantibodies in the diagnosis and management of liver diseaseAlbert J Czaja, Gary L Norman
The American Journal of Gastroenterology|October 16, 2020
Response to Granito et alAnna Reig, Gary L Norman, Albert Parés
Autoimmunity|May 27, 2003
Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitisAlbert J Czaja, Zakera Shums, Gary L Norman
Autoimmunity|October 23, 2004
Nonstandard antibodies as prognostic markers in autoimmune hepatitisAlbert J Czaja, Zakera Shums, Gary L Norman
World Journal of Gastroenterology|May 1, 2007
Utility of serological markers in inflammatory bowel diseases: gadget or magic?Maria Papp, Gary L Norman, Istvan Altorjay, et al.
Autoimmunity Reviews|June 2, 2012
Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndromeMichael Mahler, Gary L Norman, Pier Luigi Meroni, et al.
Digestive Diseases and Sciences|June 10, 2004
Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitisAlbert J Czaja, Zakera Shums, Peter T Donaldson, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|April 13, 2019
Comparison of celiac disease markers in women with early recurrent pregnancy loss and normal controlsMichael A Kutteh, May Abiad, Gary L Norman, et al.
Clinical Chemistry|March 13, 2010
Hemolysis interferes with the detection of anti-tissue transglutaminase antibodies in celiac diseaseCarolina Arguelles-Grande, Gary L Norman, Govind Bhagat, et al.
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
MLO: Medical Laboratory Observer|August 26, 2015
Fecal calprotectin: an inflammatory biomarker with emerging importance in the clinical laboratoryGary L Norman
Journal of Clinical Gastroenterology|September 25, 2003
Autoantibodies in the diagnosis and management of liver diseaseAlbert J Czaja, Gary L Norman
The American Journal of Gastroenterology|October 16, 2020
Response to Granito et alAnna Reig, Gary L Norman, Albert Parés
Autoimmunity|May 27, 2003
Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitisAlbert J Czaja, Zakera Shums, Gary L Norman
Autoimmunity|October 23, 2004
Nonstandard antibodies as prognostic markers in autoimmune hepatitisAlbert J Czaja, Zakera Shums, Gary L Norman
World Journal of Gastroenterology|May 1, 2007
Utility of serological markers in inflammatory bowel diseases: gadget or magic?Maria Papp, Gary L Norman, Istvan Altorjay, et al.
Autoimmunity Reviews|June 2, 2012
Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndromeMichael Mahler, Gary L Norman, Pier Luigi Meroni, et al.
Digestive Diseases and Sciences|June 10, 2004
Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitisAlbert J Czaja, Zakera Shums, Peter T Donaldson, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|April 13, 2019
Comparison of celiac disease markers in women with early recurrent pregnancy loss and normal controlsMichael A Kutteh, May Abiad, Gary L Norman, et al.
Clinical Chemistry|March 13, 2010
Hemolysis interferes with the detection of anti-tissue transglutaminase antibodies in celiac diseaseCarolina Arguelles-Grande, Gary L Norman, Govind Bhagat, et al.
Pageof 12